Application no. and date | 94901444.3 (espacenet) (Federated) (European Patent Register), 19931112 | Patent/reg. no. and date | DK/EP 0669836, 19960703 | Publication date | 19950906 | Priority no. and date | US 978891, 19921113, US 149099, 19931103 | EP pub. no. and date |
EP 0669836 19950906 | Effective date | | Applicant/owner | BIOGEN INC., 225 Binney Street Cambridge, MA 02142, US | Applicant ref. no. | 18392 DK 1 | Inventor | RASTETTER, William, H., 16067 Puerta Del Sol, Rancho Santa Fe, CA 92067 , US, NEWMAN, Roland, A., 43111 Robbins Street, San Diego, CA 92122 , US, HANNA, Nabil, 3255 Fortuna Ranch Road, Olivenhain, CA 92024 , US, ANDERSON, Darrell, R., 1851 Navato Place, Escondido, CA 92029 , US, LEONARD, John, E., 1960 Avenida Joaquin, Encinitas, CA 92024 , US, REFF, Mitchell, E., 4166 Combe Way, San Diego, CA 92122 , US | Representative | Plougmann Vingtoft A/S, Strandvejen 70, 2900 Hellerup, DK | Opponent | | IPC Class | A61K 43/00, C12N 15/02, C12P 21/08, A61K 39/395 | Title | Terapeutisk anvendelse af kimære og radioaktivt mærkede antistoffer og humant B-lymfocytbegrænsetdifferentieringsantigen til behandling af B-cellelymfom | Int. application no. | PCT/US93/10953 | Int. publication no. | WO/9411026 | Related patent (certificate) | CA 2004 00021 | Status | Udløbet | Pædiatrisk forlængelse | - | Udløbsdato for pædiatrisk forlængelse | - |
|